Top Stories from Western Switzerland (June 2026)

From a world-leading deeptech funding ranking to a landmark watchmaking laboratory and major life sciences raises, discover Western Switzerland’s top stories from June 2026.

Switzerland leads the world in deeptech venture funding in 2026

The Swiss Deeptech Report 2026 ranks Switzerland first worldwide for the share of venture capital flowing to deeptech, at 63%, and first in Europe per capita. EPFL in Lausanne was named among Europe’s two leading universities for deeptech spinouts.

Omega establishes the Laboratoire de Précision in Biel

Omega has launched the Laboratoire de Précision, a SAS-accredited chronometric testing facility open to the entire industry as an independent alternative to COSC. Operating across two Bernese sites, it reinforces the canton of Bern’s role as the global capital of watchmaking precision.

Fribourg’s Biofactory Competence Center turns biotech research into scalable production

The Biofactory Competence Center at Bluefactory in Fribourg helps partners across Western Switzerland move from research to production, supporting projects from regenerative medicine start-up Regenosca to GMP phage therapy production with the CHUV.

SOPHiA GENETICS raises USD 57.5 million in oversubscribed public offering

Lausanne-based SOPHiA GENETICS closed an oversubscribed public offering raising USD 57.5 million to expand its AI-driven precision medicine platform. Its SOPHiA DDM technology is used by close to 1,000 healthcare institutions worldwide for genomic and multimodal data analysis.

Cassio-P, NovoViz and Solar Loop reach the final of the 2026 Prix BCN Innovation

The Banque Cantonale Neuchâteloise named Cassio-P, NovoViz, and Solar Loop as finalists for the 17th Prix BCN Innovation, competing for the CHF 150,000 award supporting innovative projects in the canton of Neuchâtel. The winner will be announced on 1 October 2026.

MindMaze secures CHF 8 million to expand its neurotherapeutics platform

Geneva-based MindMaze Therapeutics secured CHF 8 million in strategic equity financing from Neuro.io Group to expand its US operations. The two parties also signed a letter of intent exploring a potential combination of neurotherapeutics and AI capabilities.

Western Switzerland for Robotics Companies

Western Switzerland has built one of Europe’s most distinctive robotics ecosystems by extending its 250-year precision engineering tradition into intelligent machines, spanning surgical robots, inspection drones, and the semiconductor technologies that make autonomy possible.